Mohler Emile R
Cardiovascular Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA.
Arch Intern Med. 2003 Oct 27;163(19):2306-14. doi: 10.1001/archinte.163.19.2306.
Peripheral arterial disease (PAD) is most commonly a manifestation of systemic atherosclerosis in which the arterial lumen of the lower extremities becomes progressively occluded by atherosclerotic plaque. Patients with PAD are at triple the risk of all-cause mortality and at more than 6 times the risk of death from coronary heart disease as those without the disease, yet PAD is probably the most underdiagnosed and least aggressively managed atherosclerotic disease. In the diagnosis of PAD, a detailed history and physical examination are extremely important, although limited by a lack of consistent sensitivity and specificity. Other office-based noninvasive tests, including the ankle-brachial index, can be easily performed to confirm the diagnosis and help stratify the risk. The ankle-brachial index correlates well with disease severity and functional symptoms and can also be used to assess disease progression and to predict cardiovascular and cerebrovascular mortality. Once diagnosed, risk factor modification, symptomatic relief, and secondary prevention strategies with antiplatelet agents form the core of medical management of PAD.
外周动脉疾病(PAD)通常是全身性动脉粥样硬化的一种表现,其中下肢动脉管腔逐渐被动脉粥样硬化斑块阻塞。与未患该疾病的人相比,PAD患者的全因死亡率风险高出两倍,死于冠心病的风险高出六倍多,但PAD可能是诊断最不足且治疗最不积极的动脉粥样硬化疾病。在PAD的诊断中,详细的病史和体格检查极为重要,尽管其受限于缺乏一致的敏感性和特异性。其他基于门诊的非侵入性检查,包括踝臂指数,可轻松进行以确诊并帮助分层风险。踝臂指数与疾病严重程度和功能症状密切相关,还可用于评估疾病进展以及预测心血管和脑血管死亡率。一旦确诊,改变危险因素、缓解症状以及使用抗血小板药物的二级预防策略便构成了PAD药物治疗的核心。